rs1471586847
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_001300901.2(TCEAL4):c.144dupG(p.Arg49AlafsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,165,552 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 13 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001300901.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000892 AC: 1AN: 112101Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34263
GnomAD3 exomes AF: 0.0000182 AC: 2AN: 109856Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 40124
GnomAD4 exome AF: 0.0000247 AC: 26AN: 1053451Hom.: 0 Cov.: 30 AF XY: 0.0000377 AC XY: 13AN XY: 344695
GnomAD4 genome AF: 0.00000892 AC: 1AN: 112101Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34263
ClinVar
Submissions by phenotype
Spinocerebellar ataxia 7 Uncertain:1
The NM_001300901.2: c.144dup (p.Arg49AlafsX9) is a novel de novo frameshift variant in TCEAL4, predicted to result in a truncated or absent protein product. This variant was identified in proband 14, who presented with epilepsy and neurodevelopmental disorders (NDDs) (MIM# 620114), a phenotype consistent with TCEAL4-related conditions (PP1). Sanger sequencing validated the de novo status of the variant within the affected family. The variant was classified as likely pathogenic by multiple in silico prediction tools, including Varsome, Franklin, and ClinVar, in accordance with ACMG criteria (PMID:25741868). Additionally, the variant has been previously reported in the literature as a causative variant for epilepsy-associated NDDs. In summary, this variant meets the criteria to be classified as likely pathogenic for epilepsy-associated NDDs, based on the ACMG/AMP criteria applied: PM2, PP1. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at